Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vennin

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Medical Genetics|September 1, 1996
Attitudes towards cancer predictive testing and transmission of information to the familyC Julian-Reynier, F Eisinger, P Vennin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Cancer genetics clinics: target population and consultees' expectationsC Julian-Reynier, F Eisinger, F Chabal, et al.
Gynecologic Oncology|October 20, 1999
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation studyC Lhommé, P Vennin, N Callet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast GroupT Delozier, M Spielmann, J Macé-Lesec'h, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Medical Genetics|September 1, 1996
Attitudes towards cancer predictive testing and transmission of information to the familyC Julian-Reynier, F Eisinger, P Vennin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Cancer genetics clinics: target population and consultees' expectationsC Julian-Reynier, F Eisinger, F Chabal, et al.
Gynecologic Oncology|October 20, 1999
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation studyC Lhommé, P Vennin, N Callet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast GroupT Delozier, M Spielmann, J Macé-Lesec'h, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
Pageof 7